A distinctive interaction between memory and chronic daytime somnolence in asymptomatic APOE e4 homozygotes.

STUDY OBJECTIVES To correlate memory measures with a trait measure of chronic daytime somnolence in cognitively normal individuals with different gene doses of the apolipoprotein E (APOE) e4 allele, a common Alzheimer's disease susceptibility gene. DESIGN Cross-sectional, exploratory study of cognitive abilities in APOE e4 homozygotes (HMZ) (n=42), heterozygotes (HTZ), (n=42) and noncarriers (NC) (n=42) who are matched for age, gender, educational level, and family history of dementia. SETTING Tertiary care academic medical center. PARTICIPANTS Cognitively normal residents of Maricopa County, Arizona who are 30-70 years of age, genotyped for APOE, and have no history of a sleep disorder INTERVENTIONS N/A. MEASUREMENTS Epworth Sleepiness Scale (ESS) and a battery of neuropsychological tests RESULTS Age, education, gender, and insomnia complaints did not significantly differ among groups. Despite normal baseline memory scores, memory declined with increasing ESS on all eight memory measures in the HMZ, two of eight in the HTZ, and one of eight in the NC. Differences between HMZ and NC on the slope of memory decline with increasing ESS reached statistical significance on two verbal memory measures, AVLT Long-Term Memory (p=0.048) and Percent Delayed Recall (p=0.035). CONCLUSIONS Chronic daytime somnolence is associated with a distinctive decline in verbal memory in cognitively normal APOE e4 HMZ, a group at particularly high risk of Alzheimer's disease. Additional studies are needed to confirm these exploratory findings and to determine the effects of acute somnolence on cognition in these genetic subgroups.

[1]  R. Mohs,et al.  Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. , 2002, Psychopharmacology bulletin.

[2]  Richard J. Caselli,et al.  Preclinical cognitive decline in late middle-aged asymptomatic apolipoprotein E-e4/4 homozygotes: a replication study , 2001, Journal of the Neurological Sciences.

[3]  T. Young,et al.  Association Between Apolipoprotein E e4 and Sleep-Disordered Breathing in Adults , 2017 .

[4]  Richard J. Caselli,et al.  Tracking the decline in cerebral glucose metabolism in persons and laboratory animals at genetic risk for Alzheimer's disease , 2001, Clinical Neuroscience Research.

[5]  G. Schellenberg,et al.  Increased CSF cortisol in AD is a function of APOE genotype , 2001, Neurology.

[6]  Tony W Buchanan,et al.  Enhanced memory for emotional material following stress-level cortisol treatment in humans , 2001, Psychoneuroendocrinology.

[7]  R. Chervin.  The multiple sleep latency test and Epworth sleepiness scale in the assessment of daytime sleepiness , 2000, Journal of sleep research.

[8]  S. Carreau,et al.  Rat Leydig cells use apolipoprotein E depleted high density lipoprotein to regulate testosterone production , 2000, Molecular and Cellular Biochemistry.

[9]  D. R. Gross,et al.  Link between heart disease, cholesterol, and Alzheimer's disease: A review , 2000, Microscopy research and technique.

[10]  Jon C. Cole,et al.  Chronic Jet Lag Produces Cognitive Deficits , 2000, The Journal of Neuroscience.

[11]  M. Johns,et al.  Sensitivity and specificity of the multiple sleep latency test (MSLT), the maintenance of wakefulness test and the Epworth sleepiness scale: Failure of the MSLT as a gold standard , 2000, Journal of sleep research.

[12]  H. Cohen,et al.  Cognitive decline in patients with Cushing's syndrome , 2000, Journal of the International Neuropsychological Society.

[13]  B. Teter,et al.  Role of apolipoprotein E and estrogen in mossy fiber sprouting in hippocampal slice cultures , 1999, Neuroscience.

[14]  Eric M. Reiman,et al.  Preclinical memory decline in cognitively normal apolipoprotein E–ε4 homozygotes , 1999, Neurology.

[15]  R. Hauger,et al.  Working memory is more sensitive than declarative memory to the acute effects of corticosteroids: a dose-response study in humans. , 1999, Behavioral neuroscience.

[16]  S. Ancoli-Israel,et al.  Daytime consequences and correlates of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. II. , 1999, Sleep.

[17]  E. Tangalos,et al.  Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .

[18]  E. Mascha,et al.  Association between the Epworth sleepiness scale and the multiple sleep latency test in a clinical population. , 1999 .

[19]  R. Chervin,et al.  The Epworth Sleepiness Scale may not reflect objective measures of sleepiness or sleep apnea , 1999, Neurology.

[20]  M. Cole,et al.  Correlations among Epworth Sleepiness Scale scores, multiple sleep latency tests and psychological symptoms , 1998, Journal of sleep research.

[21]  M N Rossor,et al.  Presymptomatic cognitive deficits in individuals at risk of familial Alzheimer's disease. A longitudinal prospective study. , 1998, Brain : a journal of neurology.

[22]  D. Greenblatt,et al.  ApoE-epsilon 4 allele and susceptibility to drug-induced memory impairment in the elderly. , 1998, Journal of clinical psychopharmacology.

[23]  T. Lehtimäki,et al.  No relation between apolipoprotein E alleles and obstructive sleep apnea , 1998, Clinical genetics.

[24]  A. Roses,et al.  ApoE, Alzheimer's Disease, and Recovery from Brain Stress a , 1997, Annals of the New York Academy of Sciences.

[25]  J. DeLuca,et al.  Neuropsychology of chronic fatigue syndrome: a critical review. , 1997, Journal of clinical and experimental neuropsychology.

[26]  David C. Steffens,et al.  A twin study of late-onset depression and apolipoprotein E ε4 as risk factors for alzheimer's disease , 1997, Biological Psychiatry.

[27]  R. Chervin,et al.  Comparison of the results of the Epworth Sleepiness Scale and the Multiple Sleep Latency Test. , 1997, Journal of psychosomatic research.

[28]  Yaakov Stern,et al.  Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease , 1996, The Lancet.

[29]  N Butters,et al.  Episodic memory changes are associated with the APOE- epsilon 4 allele in nondemented older adults , 1995, Neurology.

[30]  K. Marder,et al.  Neuropsychological detection and characterization of preclinical Alzheimer's disease , 1995, Neurology.

[31]  M. Johns,et al.  Sleepiness in different situations measured by the Epworth Sleepiness Scale. , 1994, Sleep.

[32]  D. Carmelli,et al.  Lower Cognitive Performance in Normal Older Adult Male Twins Carrying the Apolipoprotein E ε4 Allele , 1994 .

[33]  M. Sliwinski,et al.  Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons , 1994, Neurology.

[34]  E G Tangalos,et al.  Memory function in very early Alzheimer's disease , 1994, Neurology.

[35]  A. D. Roses,et al.  Association of apolipoprotein E allele €4 with late-onset familial and sporadic Alzheimer’s disease , 2006 .

[36]  M. Folstein,et al.  Population-based norms for the Mini-Mental State Examination by age and educational level. , 1993, JAMA.

[37]  M. Johns,et al.  A new method for measuring daytime sleepiness: the Epworth sleepiness scale. , 1991, Sleep.

[38]  D J Ballard,et al.  Clinical risk factors for Alzheimer's disease , 1991, Neurology.

[39]  P. Forgez,et al.  Expression of the human apolipoprotein E gene suppresses steroidogenesis in mouse Y1 adrenal cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[40]  D. T. Vernier,et al.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. , 1990, Journal of lipid research.

[41]  J. Morris,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assesment of Alzheimer's disease , 1989, Neurology.

[42]  R. Mahley,et al.  Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. , 1988, Science.

[43]  R. Sapolsky,et al.  Stress and glucocorticoids in aging. , 1987, Endocrinology and metabolism clinics of North America.

[44]  J. Botwinick,et al.  A longitudinal, behavioral study of senile dementia of the Alzheimer type. , 1986, Archives of neurology.

[45]  B. McEwen,et al.  The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. , 1986, Endocrine reviews.

[46]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[47]  T. Trauer,et al.  Neuropsychological Assessment. Second Edition , 1984 .

[48]  R. Cattell,et al.  The Nature of Anxiety: A Review of Thirteen Multivariate Analyses Comprising 814 Variables , 1958 .

[49]  S. Money,et al.  Comparison of open transabdominal AAA repair with endovascular AAA repair in reduction of postoperative stress response , 2001 .

[50]  S. Heck,et al.  The female sex hormone oestrogen as neuroprotectant: activities at various levels. , 2000, Novartis Foundation symposium.

[51]  B. McEwen,et al.  Increased Cortisol Levels and Impaired Cognition in Human Aging: Implication for Depression and Dementia in Later Life , 1999, Reviews in the neurosciences.

[52]  Claude Bouchard,et al.  Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: Executive summary , 1998 .

[53]  J. Pépin,et al.  Deficits of cognitive executive functions in patients with sleep apnea syndrome. , 1995, Sleep.